Chemoinformaics analysis of METHANONE, (4-METHOXYPHENYL)(5,6,7-TRIMETHOXY-1-ISOQUINOLINYL)-
| Molecular Weight | 353.374 | nRot | 6 |
| Heavy Atom Molecular Weight | 334.222 | nRig | 18 |
| Exact Molecular Weight | 353.126 | nRing | 3 |
| Solubility: LogS | -4.298 | nHRing | 1 |
| Solubility: LogP | 2.978 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 51.1791 |
| nHD | 0 | BPOL | 28.0129 |
| QED | 0.632 |
| Synth | 2.151 |
| Natural Product Likeliness | 0.094 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.952 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.635 |
| MDCK | 0.0000406 |
| BBB | 0.266 |
| PPB | 0.849569 |
| VDSS | 0.786 |
| FU | 0.109367 |
| CYP1A2-inh | 0.56 |
| CYP1A2-sub | 0.964 |
| CYP2c19-inh | 0.805 |
| CYP2c19-sub | 0.839 |
| CYP2c9-inh | 0.655 |
| CYP2c9-sub | 0.897 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.894 |
| CYP3a4-inh | 0.804 |
| CYP3a4-sub | 0.681 |
| CL | 7.646 |
| T12 | 0.296 |
| hERG | 0.672 |
| Ames | 0.73 |
| ROA | 0.276 |
| SkinSen | 0.171 |
| Carcinogencity | 0.343 |
| EI | 0.06 |
| Respiratory | 0.861 |
| NR-Aromatase | 0.824 |
| Antiviral | Yes |
| Prediction | 0.878187 |